Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Influenza

Free Subscription 01.12.2025 1 BMC Pediatr 1 Epidemiol Infect 1 J Infect Dis 14 J Virol 3 PLoS Comput Biol 2 PLoS One 3 Proc Natl Acad Sci U S A 11 Vaccine 4 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Pediatr

1. KIM S, Talluri R, Yu A, Evans M, et al
   The effect of the COVID-19 pandemic on racial disparities in suicide and homicide by firearm rates in Missouri.
   BMC Pediatr. 2025;25:953.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

2. CHUA H, Tsang TKL, Lee SL, Chan ELY, et al
   Waning in influenza vaccine effectiveness against influenza A(H1N1)pdm09-associated hospitalization in children in 2012/13.
   Epidemiol Infect. 2025 Nov 24:1-25. doi: 10.1017/S0950268825100770.
   PubMed        
   
   

   
   J Infect Dis

3. ZHANG X, Lam SJ, Chen LL, Fong CH, et al
   Avian influenza virus A(H5N1) genotype D1.1 is better adapted to human nasal and airway organoids than genotype B3.13.
   J Infect Dis. 2025 Nov 24:jiaf598. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

4. MITCHELL JK, Mastrodomenico V, Hartnett J, Heelan WJ, et al
   A HiBiT-tagged pseudovirus-like particle platform for safe, rapid quantification of virus neutralization and antibody-dependent enhancement.
   J Virol. 2025 Oct 8:e0099125. doi: 10.1128/jvi.00991.
   PubMed         Abstract available
   
   
5. WANG W, Du P, Zhao Y, Liang Y, et al
   Biomimetic nanovaccines with self-adjuvant effects induced broad-spectrum neutralizing antibodies against SARS-CoV-2 infection in rodents.
   J Virol. 2025 Oct 10:e0031525. doi: 10.1128/jvi.00315.
   PubMed         Abstract available
   
   
6. DADONAITE B, Harari S, Larsen BB, Kampman L, et al
   Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants.
   J Virol. 2025 Oct 13:e0142325. doi: 10.1128/jvi.01423.
   PubMed         Abstract available
   
   
7. DING S, Yang D, Ullah I, Niu L, et al
   Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants.
   J Virol. 2025 Oct 13:e0103425. doi: 10.1128/jvi.01034.
   PubMed         Abstract available
   
   
8. DETTE A, Moers F, Mayr T, Stillfried Sv, et al
   Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19.
   J Virol. 2025 Oct 29:e0138425. doi: 10.1128/jvi.01384.
   PubMed         Abstract available
   
   
9. JOHNSON KEE, Stein S, Boateng RA, Jain S, et al
   Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19.
   J Virol. 2025 Oct 31:e0085725. doi: 10.1128/jvi.00857.
   PubMed         Abstract available
   
   
10. WANG C, Shuai L, Zhong G, Wen Z, et al
    Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity.
    J Virol. 2025 Nov 4:e0156625. doi: 10.1128/jvi.01566.
    PubMed         Abstract available
    
    
11. IRELAND J, Myers D, Huang C, Allen C, et al
    Vaccination protects against COVID-associated pulmonary fibrin deposition.
    J Virol. 2025 Nov 6:e0063325. doi: 10.1128/jvi.00633.
    PubMed         Abstract available
    
    
12. POWERS JM, Leist SR, Suryadevara N, Zost SJ, et al
    Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice.
    J Virol. 2025 Nov 6:e0140625. doi: 10.1128/jvi.01406.
    PubMed         Abstract available
    
    
13. ZHAO M, Zhang Y, Liang Y, Lei F, et al
    SARS-CoV-2 polyprotein expression and the induction of double-membrane vesicles.
    J Virol. 2025 Nov 6:e0138525. doi: 10.1128/jvi.01385.
    PubMed         Abstract available
    
    
14. YU W, He X, Zhao J, Dou Y, et al
    Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse model.
    J Virol. 2025 Nov 24:e0132725. doi: 10.1128/jvi.01327.
    PubMed         Abstract available
    
    
15. SHEN W, Xu J, Chen Z, Wei Y, et al
    Broad-spectrum inhibition of influenza A virus replication by blocking the nuclear export of viral ribonucleoprotein complexes.
    J Virol. 2025 Nov 25:e0147825. doi: 10.1128/jvi.01478.
    PubMed         Abstract available
    
    
16. SAUL S, Dahal B, Luongo C, Liu X, et al
    Intranasal bovine/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters.
    J Virol. 2025 Nov 25:e0114525. doi: 10.1128/jvi.01145.
    PubMed         Abstract available
    
    
17. HUANG J, Xu S, Liu J, Wang Q, et al
    The viral proteins of influenza A virus competitively bind to TRIM31 with MAVS to fine-tune the antiviral innate immunity.
    J Virol. 2025 Nov 26:e0189325. doi: 10.1128/jvi.01893.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

18. GOZZI N, Chinazzi M, Davis JT, Gioannini C, et al
    Epydemix: An open-source Python package for epidemic modeling with integrated approximate Bayesian calibration.
    PLoS Comput Biol. 2025;21:e1013735.
    PubMed         Abstract available
    
    
19. TANG J, Rumack A, Wilder B, Rosenfeld R, et al
    Real-time forecasting of data revisions in epidemic surveillance streams.
    PLoS Comput Biol. 2025;21:e1013709.
    PubMed         Abstract available
    
    
20. WICHMANN RM, Robiati Bigoto MA, Chiavegatto Filho ADP
    Federated learning for COVID-19 mortality prediction in a multicentric sample of 21 hospitals.
    PLoS Comput Biol. 2025;21:e1013695.
    PubMed         Abstract available
    
    

    
    PLoS One

21. FISHER SS, Lindaas A, Muthuri SG, Lloyd PC, et al
    Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.
    PLoS One. 2025;20:e0333704.
    PubMed         Abstract available
    
    
22. GUAN W, Liu M, Rong S, Liu T, et al
    Analysis of arrhythmia and its risk factors in patients with COVID-19.
    PLoS One. 2025;20:e0336370.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. OKADA T, Isacchini G, Yu Q, Hallatschek O, et al
    Uncovering heterogeneous intercommunity disease transmission from neutral allele frequency time series.
    Proc Natl Acad Sci U S A. 2025;122:e2500663122.
    PubMed         Abstract available
    
    
24. CAI J, Wu Y, Liu H, Deng Z, et al
    China's post-zero-COVID Omicron wave: A Bayesian analysis.
    Proc Natl Acad Sci U S A. 2025;122:e2514157122.
    PubMed         Abstract available
    
    
25. CAPUCETTI A, Falivene J, Pizzichetti C, Latino I, et al
    Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2510392122.
    PubMed         Abstract available
    
    

    
    Vaccine

26. HUANG F, Deng Z, Huang Y, Lv Q, et al
    COVID-19 as a catalyst? Uptake and drivers of seasonal influenza and pneumococcal vaccination among older adults in post-pandemic Shenzhen, China.
    Vaccine. 2025;69:128013.
    PubMed         Abstract available
    
    
27. CHILVER M, Ahsani Z, Sullivan SG, Edwards J, et al
    Evaluating the role of self-collected home swab data in enhancing influenza vaccine effectiveness estimates in general practice.
    Vaccine. 2025;69:127994.
    PubMed         Abstract available
    
    
28. CARACO Y, Madar-Balakirski N, Ben-Ami E, Zeltser D, et al
    Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults.
    Vaccine. 2025;67:127837.
    PubMed         Abstract available
    
    
29. OIKAWA K, Murakami M, Ochi S, Yamagata M, et al
    Contributing factors to reversed willingness to vaccinate after the COVID-19 pandemic: Insights from a national panel survey.
    Vaccine. 2025;67:127869.
    PubMed         Abstract available
    
    
30. MERCADANTE E, Minssen T, Shadlen KC, van Zimmeren E, et al
    A global landscape of patenting activity in COVID-19 vaccines.
    Vaccine. 2025;67:127866.
    PubMed         Abstract available
    
    
31. MALTEZOU HC, Drositis I, Sourri F, Tseroni M, et al
    Understanding the attitudes of unvaccinated COVID-19 patients hospitalized in Greece toward the 2024-2025 booster COVID-19 vaccine.
    Vaccine. 2025;67:127829.
    PubMed         Abstract available
    
    
32. EAGAN RL, Claessens T, Hendrickx G, Larson HJ, et al
    The state of vaccine confidence among the general public in Eastern Europe and Central Asia.
    Vaccine. 2025;67:127849.
    PubMed         Abstract available
    
    
33. PORTER A, Cooper S, King A, Presti C, et al
    Regional voices, different choices: Parents' and caregivers' HPV vaccine attitudes in the northeast and Southeast United States.
    Vaccine. 2025;67:127864.
    PubMed         Abstract available
    
    
34. ASTURIAS EJ, Chen LH, Shaw AC, Moser CA, et al
    Science for vaccine policy: Independent review of the September 2025 ACIP processes, deliberations and votes.
    Vaccine. 2025;67:127876.
    PubMed         Abstract available
    
    
35. ABDUL AZIZ N, Kirsebom FCM, Allen A, Andrews N, et al
    Effectiveness of spring 2024 (XBB.1.5) and autumn 2024 (JN.1) COVID-19 vaccination against hospitalisation in England.
    Vaccine. 2025;67:127870.
    PubMed         Abstract available
    
    
36. ULRICH AK, Bigalke L, Arpey M, Redepenning S, et al
    Funding the priorities of the influenza vaccines research and development roadmap: an evaluation of global investment.
    Vaccine. 2025;69:127967.
    PubMed         Abstract available
    
    

    
    Virus Res

37. GABBAY U, Carmi D
    The Paradox of Rapid and Synchronized Propagation of Seasonal Influenza 'A' Outbreaks in Contrast with COVID-19: a Testable Hypothesis.
    Virus Res. 2025 Nov 26:199670. doi: 10.1016/j.virusres.2025.199670.
    PubMed         Abstract available
    
    
38. LI X, Xiao M
    Retrospective study on the correlation between biochemical and blood routine indexes and prognosis in elderly patients with influenza A (H1N1).
    Virus Res. 2025;362:199668.
    PubMed         Abstract available
    
    
39. HU J, Liu M, Qin B, Shen B, et al
    D-dimer drives immune dysregulation in COVID-19 via chemokine modulation and inflammatory signaling.
    Virus Res. 2025;361:199641.
    PubMed         Abstract available
    
    
40. VOKO Z, Turi G, Oroszi B, Belicza E, et al
    Association between COVID-19 vaccination and progression to severe outcomes in hospitalized COVID-19 patients in Hungary during the pre-Omicron era of the COVID-19 pandemic.
    Virus Res. 2025;361:199633.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.